Propofol prevents renal ischemia-reperfusion injury via inhibiting the oxidative stress pathways

Cellular Physiology and Biochemistry

Volumn 37, Issue 1, 2015, Pages 14-26

  Li, Yingjie ^a   Zhong, Dandan ^a   Lei, Lei ^a   Jia, Yingli ^a   Zhou, Hong ^a   Yang, Baoxue ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Anesthetic; Endoplasmic reticulum stress; Mitochondrial stress; NRK 52E cell; Propofol; Renal ischemia reperfusion injury

Indexed keywords

CASPASE 12; CASPASE 3; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PROPOFOL; PROTEIN BAX; PROTEIN BCL 2; DDIT3 PROTEIN, RAT; HEAT SHOCK PROTEIN; HSPA5 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; ANIMAL; DRUG EFFECTS; KIDNEY; METABOLISM; WISTAR RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 12; CASPASE 3; HEAT-SHOCK PROTEINS; KIDNEY; MALE; OXIDATIVE STRESS; PROPOFOL; RATS; RATS, WISTAR; REPERFUSION INJURY; TRANSCRIPTION FACTOR CHOP;

EID: 84939506777     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430329     Document Type: Article

References (66)

1. Bolli R, Becker L, Gross G, Mentzer RJ, Balshaw D, Lathrop DA: Myocardial protection at a crossroads: The need for translation into clinical therapy. Circ Res 2004;95:125-134
2. Warach S, Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004;35:2659-2661
3. Yeh ST, Lee HL, Aune SE, Chen CL, Chen YR, Angelos MG: Preservation of mitochondrial function with cardiopulmonary resuscitation in prolonged cardiac arrest in rats. J Mol Cell Cardiol 2009;47:789-797
4. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ: Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000;32:169-173
5. Aigner F, Maier HT, Schwelberger HG, Wallnofer EA, Amberger A, Obrist P, Berger T, Mak TW, Maglione M, Margreiter R, Schneeberger S, Troppmair J: Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007;7:779-788
6. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 2004;364:1814-1827
7. Tabara LC, Poveda J, Martin-Cleary C, Selgas R, Ortiz A, Sanchez-Nino MD: Mitochondria-targeted therapies for acute kidney injury. Expert Rev Mol Med 2014;16:e13
8. Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 2012;380:756-766
9. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin J Am Soc Nephrol 2006;1:43-51
10. Chawla LS, Kimmel PL: Acute kidney injury and chronic kidney disease: An integrated clinical syndrome. Kidney Int 2012;82:516-524
11. Aragno M, Cutrin JC, Mastrocola R, Perrelli MG, Restivo F, Poli G, Danni O, Boccuzzi G: Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: Attenuation by dehydroepiandrosterone. Kidney Int 2003;64:836-843
12. Lameire N, Vanholder R: Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol 2001;12:S20-S32
13. Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, Chu T, Forrer F, Muller C, de Jong M, van IJcken W, IJzermans JN, Hoeijmakers JH, de Bruin RW: Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 2010;9:40-53
14. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011;121:4210-4221
15. Wang JC, Zhao Y, Chen SJ, Long J, Jia QQ, Zhai JD, Zhang Q, Chen Y, Long HB: AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-kappaB pathway in rat mesangial cells: Inhibition by sesquiterpene lactones. Cell Physiol Biochem 2013;32:1867-1877
16. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003;14:2199-2210
17. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC: P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: Protective role of a p53 inhibitor. J Am Soc Nephrol 2003;14:128-138
18. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 2003;63:1714-1724
19. Ozturk H, Ozturk H, Terzi EH, Ozgen U, Duran A, Uygun I: Protective effects of rosmarinic acid against renal ischaemia/reperfusion injury in rats. J Pak Med Assoc 2014;64:260-265
20. Ye S, Zhu Y, Ming Y, She X, Liu H, Ye Q: Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling. Exp Ther Med 2014;7:1247-1252
21. Li YW, Zhang Y, Zhang L, Li X, Yu JB, Zhang HT, Tan BB, Jiang LH, Wang YX, Liang Y, Zhang XS, Wang WS, Liu HG: Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene 2014;542:46-51
22. Hu H, Jiang W, Xi X, Zou C, Ye Z: MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice. Am J Nephrol 2014;40:215-223
23. Hu L, Yang C, Zhao T, Xu M, Tang Q, Yang B, Rong R, Zhu T: Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation. J Surg Res 2012;176:260-266
24. Zhang J, Zou YR, Zhong X, Ding H, Deng F, Pu L, Peng K, Wang L: Erythropoietin pretreatment Ameliorates Renal Ischemia-Reperfusion Injury by activating PI3K/Akt signaling. Nephrology (Carlton) 2015;20:266-272 25
25. Wang B, Wan J, Gong X, Kuang G, Cheng X, Min S: Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production. Int Immunopharmacol 2015;25:148-154
26. Wu K, Li H, Tian J, Lei W: Protective effect of baicalein on renal ischemia/reperfusion injury in the rat. Ren Fail 2014:1-7
27. Wu K, Lei W, Tian J, Li H: Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats. BMC Nephrol 2014;15:14
28. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002;13:2288-2298
29. Kim SM, Kim SW, Jung YJ, Min SI, Min SK, Kim SJ, Ha J: Preconditioning with thyroid hormone (3,5,3-triiodothyronine) prevents renal ischemia-reperfusion injury in mice. Surgery 2014;155:554-561
30. Ferreyra C, Vargas F, Rodriguez-Gomez I, Perez-Abud R, O'Valle F, Osuna A: Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. PLoS One 2013;8:e74960
31. Xie LB, Zeng DY, Wang XD, Lin T, Li YP, Lu YP: Preconditioning with gabexate is superior to inosine for ameliorating acute renal ischemia-reperfusion injury in rats. Transplant Proc 2014;46:40-45
32. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007;376:1-43
33. Borgeat A, Wilder-Smith OH, Suter PM: The nonhypnotic therapeutic applications of propofol. Anesthesiology 1994;80:642-656
34. Soppitt AJ, Glass PS, Howell S, Weatherwax K, Gan TJ: The use of propofol for its antiemetic effect: A survey of clinical practice in the United States. J Clin Anesth 2000;12:265-269
35. Lin C, Sui H, Gu J, Yang X, Deng L, Li W, Ding W, Li D, Yang Y: Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats. Microvasc Res 2013;90:162-168
36. Yang SC, Chung PJ, Ho CM, Kuo CY, Hung MF, Huang YT, Chang WY, Chang YW, Chan KH, Hwang TL: Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1. J Immunol 2013;190:6511-6519
37. Cui DR, Wang L, Jiang W, Qi AH, Zhou QH, Zhang XL: Propofol prevents cerebral ischemia-triggered autophagy activation and cell death in the rat hippocampus through the NF-kappaB/p53 signaling pathway. Neuroscience 2013;246:117-132
38. Yao W, Luo G, Zhu G, Chi X, Zhang A, Xia Z, Hei Z: Propofol activation of the Nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model. Oxid Med Cell Longev 2014;2014:258567
39. Luo C, Yuan D, Li X, Yao W, Luo G, Chi X, Li H, Irwin MG, Xia Z, Hei Z: Propofol Attenuated Acute Kidney Injury after Orthotopic Liver Transplantation via Inhibiting Gap Junction Composed of Connexin 32. Anesthesiology 2015;122:72-86
40. Gang GT, Hwang JH, Kim YH, Noh JR, Kim KS, Jeong JY, Choi DE, Lee KW, Jung JY, Shong M, Lee CH: Protection of NAD(P)H:quinone oxidoreductase 1 against renal ischemia/reperfusion injury in mice. Free Radic Biol Med 2014;67:139-149
41. Lindsay TF, Liauw S, Romaschin AD, Walker PM: The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 1990;12:8-15
42. Zhao WY, Han S, Zhang L, Zhu YH, Wang LM, Zeng L: Mitochondria-targeted antioxidant peptide SS31 prevents hypoxia/reoxygenation-induced apoptosis by down-regulating p66Shc in renal tubular epithelial cells. Cell Physiol Biochem 2013;32:591-600
43. Zou C, Hu H, Xi X, Shi Z, Wang G, Huang X: Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity. J Surg Res 2013;184:1092-1095
44. Qiao X, Li RS, Li H, Zhu GZ, Huang XG, Shao S, Bai B: Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress. Am J Physiol Renal Physiol 2013;304:F112-F119
45. Chikutei K, Oyama TM, Ishida S, Okano Y, Kobayashi M, Matsui H, Horimoto K, Nishimura Y, Ueno SY, Oyama Y: Propofol, an anesthetic possessing neuroprotective action against oxidative stress, promotes the process of cell death induced by H2O2 in rat thymocytes. Eur J Pharmacol 2006;540:18-23
46. Do SH, Ham BM, Zuo Z: Effects of propofol on the activity of rat glutamate transporter type 3 expressed in Xenopus oocytes: The role of protein kinase C. Neurosci Lett 2003;343:113-116
47. King N, Al SM, Suleiman MS: Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion. Pflugers Arch 2012;464:513-522
48. Shirakawa M, Imura H, Nitta T: Propofol protects the immature rabbit heart against ischemia and reperfusion injury: Impact on functional recovery and histopathological changes. Biomed Res Int 2014;2014:601250
49. Hsu HT, Tseng YT, Hsu YY, Cheng KI, Chou SH, Lo YC: Propofol attenuates Lipopolysaccharide-Induced reactive oxygen species production through activation of Nrf2/GSH and suppression of NADPH oxidase in human alveolar epithelial cells. Inflammation 2014
50. Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, Shi L, Ren H, Du H: Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med 2013;11:24
51. Lin C, Sui H, Gu J, Yang X, Deng L, Li W, Ding W, Li D, Yang Y: Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats. Microvasc Res 2013;90:162-168
52. Zhong Y, Liang Y, Chen J, Li L, Qin Y, Guan E, He D, Wei Y, Xie Y, Xiao Q: Propofol inhibits proliferation and induces neuroapoptosis of hippocampal neurons in vitro via downregulation of NF-kappaB p65 and Bcl-2 and upregulation of caspase-3. Cell Biochem Funct 2014;32:720-729
53. Messlik A, Schmechel S, Kisling S, Bereswill S, Heimesaat MM, Fischer A, Gobel U, Haller D: Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation. J Proteome Res 2009;8:4406-4417
54. Dejeans N, Tajeddine N, Beck R, Verrax J, Taper H, Gailly P, Calderon PB: Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells. Biochem Pharmacol 2010;79:1221-1230
55. Toth A, Nickson P, Mandl A, Bannister ML, Toth K, Erhardt P: Endoplasmic reticulum stress as a novel therapeutic target in heart diseases. Cardiovasc Hematol Disord Drug Targets 2007;7:205-218
56. Chen BL, Sheu ML, Tsai KS, Lan KC, Guan SS, Wu CT, Chen LP, Hung KY, Huang JW, Chiang CK, Liu SH: CCAAT-Enhancer-Binding protein homologous protein deficiency attenuates oxidative stress and renal Ischemia-Reperfusion injury. Antioxid Redox Signal 2014
57. Dong B, Zhou H, Han C, Yao J, Xu L, Zhang M, Fu Y, Xia Q: Ischemia/reperfusion-induced CHOP expression promotes apoptosis and impairs renal function recovery: The role of acidosis and GPR4. PLoS One 2014;9:e110944
58. Gao X, Fu L, Xiao M, Xu C, Sun L, Zhang T, Zheng F, Mei C: The nephroprotective effect of tauroursodeoxycholic acid on ischaemia/reperfusion-induced acute kidney injury by inhibiting endoplasmic reticulum stress. Basic Clin Pharmacol Toxicol 2012;111:14-23
59. Yu W, Sheng M, Xu R, Yu J, Cui K, Tong J, Shi L, Ren H, Du H: Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med 2013;11:24
60. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001;98:13681-13686
61. Gepts E, Camu F, Cockshott ID, Douglas EJ: Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987;66:1256-1263
62. Short TG, Aun CS, Tan P, Wong J, Tam YH, Oh TE: A prospective evaluation of pharmacokinetic model controlled infusion of propofol in paediatric patients. Br J Anaesth 1994;72:302-306
63. He XY, Shi XY, Yuan HB, Xu HT, Li YK, Zou Z: Propofol attenuates hypoxia-induced apoptosis in alveolar epithelial type II cells through down-regulating hypoxia-inducible factor-1alpha. Injury 2012;43:279-283
64. Wang HH, Zhou HY, Chen CC, Zhang XL, Cheng G: Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacol Sin 2007;28:1175-1180
65. Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T: Protective effects of propofol against ischemia/ reperfusion injury in rat kidneys. Ren Fail 2010;32:578-583
66. Assad AR, Delou JM, Fonseca LM, Villela NR, Nascimento JH, Vercosa N, Lopes AG, Capella MA: The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion. Anesth Analg 2009;109:1486-1492